Free Trial
OTCMKTS:BICX

Biocorrx Q2 2026 Earnings Results & Report

Biocorrx logo
$0.21 0.00 (0.00%)
As of 11/13/2026 10:26 AM Eastern

Biocorrx beat analyst earnings expectations but missed on revenue in its Q2 2026 results, released August 14, 2026. The company reported EPS of -$0.03 versus the -$0.05 consensus estimate, while revenue of $88 thousand fell short of the $240 thousand estimate by $152 thousand.

Earnings Announcement Details

Quarter
Q2 2026
Report Date
Time
During Market Hours

Biocorrx EPS Results

Actual EPS
-$0.03
Consensus EPS
-$0.05
Beat/Miss
Beat by +$0.02
One Year Ago EPS
N/A
EPS Beat Rate
3 of last 4 quarters

Biocorrx Revenue Results

Actual Revenue
$88 thousand
Expected Revenue
$240 thousand
Beat/Miss
Missed by -$152.00 thousand
YoY Revenue Growth
N/A

Upcoming Earnings

Biocorrx's next earnings date is estimated for Tuesday, November 17, 2026, based on past reporting schedules.

Biocorrx Q2 2026 Earnings FAQ

Biocorrx (OTCMKTS:BICX) reported earnings of -$0.03 per share for Q2 2026, beating the consensus estimate of -$0.05. The report was announced on Friday, August 14, 2026.

Biocorrx reported revenue of $88 thousand for Q2 2026, against a consensus estimate of $240 thousand.

Biocorrx's next earnings date is estimated for Tuesday, November 17, 2026. MarketBeat tracks confirmed and estimated earnings dates for Biocorrx on the company's earnings history page.

Biocorrx Earnings Headlines

Biocorrx (BICX) Projected to Release Quarterly Earnings on Tuesday
BioCorRx Inc
My public warning after 55 years of watching the markets
Dr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each warning issued before the crisis hit. Now the founder of Weiss Ratings, the only conflict-free rating agency in America, says he is watching a $3 trillion problem that could trigger a chain reaction across markets and banks.tc pixel
BioCorRx Inc.
See More Biocorrx Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Biocorrx? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Biocorrx and other key companies, straight to your email.

About Biocorrx

Biocorrx (OTCMKTS:BICX), Inc. is a healthcare company focused on substance-use-disorder treatment and related products. Its BioCorRx Recovery Program is an outpatient approach that combines medication-assisted treatment with counseling and ongoing support for people seeking treatment for alcohol or opioid dependence.

The company has also pursued pharmaceutical products intended to support addiction treatment, including long-acting formulations. Its business includes developing treatment offerings and working to make them available through healthcare providers.

BioCorRx has also offered UnCraveRx, a medically supervised weight-management program. Its activities are centered on treatment and support services rather than traditional pharmaceutical manufacturing or general medical care.

View Biocorrx Profile